Epidemiology and Clinical Features of Post-Transplant Bloodstream Infection: An Analysis of 222 Consecutive Liver Transplant Recipients
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Bloodstream infection (BSI) is a significant cause of morbidity and mortality in liver transplant (LT) recipients. This study aimed to investigate the epidemiology and clinical features of post-transplant BSI in LT recipients. Materials and Methods: The microbiology, frequency, and outcome of post-transplant BSI in the first year after LT were retrospectively analyzed in 222 consecutive patients who had received liver transplants at a single center between 2005 and 2011. The risk factors for post-transplant BSI and death were evaluated. Results: During a 1-year period after LT, 112 episodes of BSI occurred in 64 of the 222 patients (28.8%). A total of 135 microorganisms were isolated from 112 BSI episodes including 18 polymicrobial episodes. The median time to BSI onset ranged from 8 days for Klebsiella pneumoniae to 101 days for enterococci, and the overall median for all microorganisms was 28 days. The most frequent pathogens were Enterobacteriaceae members (32.5%), enterococci (17.8%), yeasts (14.0%), Staphylococcus aureus (10.3%), and Acinetobacter baumannii (10.3%); most of them showed resistance to major antibiotics. The major sources of BSI were biliary tract (36.2%), abdominal and/or wound (28.1%), and intravascular catheter (18.5%) infections. The independent risk factors for post-transplant BSI were biliary complications (odds ratio [OR]: 2.91, 95% confidence interval [CI]: 1.29to 6.59, P = 0.010) and longer hospitalization in the intensive care unit (OR: 1.04, 95% CI: 1.00 to 1.08, P < 0.001) after LT. BSI was an independent risk factor for death (hazard ratio [HR]: 3.92, 95% CI: 2.22 to 6.91, P < 0.001), with a poorer survival rate observed in patients with BSI than in those without BSI (1-year survival rate: 60.0% versus 89.5%, respectively, P < 0.001)after LT. The strongest predictors for death in patients with BSI were hepatocellular carcinoma (HR: 3.82, 95% CI: 1.57 to 9.32,P = 0.003), candidemia (HR: 3.71, 95% CI: 1.58 to 8.71, P = 0.003), polymicrobial bacteremia (HR: 3.18, 95% CI: 1.39 to 7.28,P = 0.006), and post-transplant hemodialysis (HR: 2.44, 95% CI: 1.02 to 5.84, P = 0.044). Conclusions: BSI was a frequent post-transplant complication, and most of the causative pathogens were multi-drug resistant. Biliary complications and BSIs resulting from biliary infection are major problems for LT recipients. The prevention of BSI and biliary complications is critical in improving prognosis in liver transplant recipients.
Abstract
Background: Bloodstream infection (BSI) is a significant cause of morbidity and mortality in liver transplant (LT) recipients. This study aimed to investigate the epidemiology and clinical features of post-transplant BSI in LT recipients. Materials and Methods: The microbiology, frequency, and outcome of post-transplant BSI in the first year after LT were retrospectively analyzed in 222 consecutive patients who had received liver transplants at a single center between 2005 and 2011. The risk factors for post-transplant BSI and death were evaluated. Results: During a 1-year period after LT, 112 episodes of BSI occurred in 64 of the 222 patients (28.8%). A total of 135 microorganisms were isolated from 112 BSI episodes including 18 polymicrobial episodes. The median time to BSI onset ranged from 8 days for Klebsiella pneumoniae to 101 days for enterococci, and the overall median for all microorganisms was 28 days. The most frequent pathogens were Enterobacteriaceae members (32.5%), enterococci (17.8%), yeasts (14.0%), Staphylococcus aureus (10.3%), and Acinetobacter baumannii (10.3%); most of them showed resistance to major antibiotics. The major sources of BSI were biliary tract (36.2%), abdominal and/or wound (28.1%), and intravascular catheter (18.5%) infections. The independent risk factors for post-transplant BSI were biliary complications (odds ratio [OR]: 2.91, 95% confidence interval [CI]: 1.29to 6.59, P = 0.010) and longer hospitalization in the intensive care unit (OR: 1.04, 95% CI: 1.00 to 1.08, P < 0.001) after LT. BSI was an independent risk factor for death (hazard ratio [HR]: 3.92, 95% CI: 2.22 to 6.91, P < 0.001), with a poorer survival rate observed in patients with BSI than in those without BSI (1-year survival rate: 60.0% versus 89.5%, respectively, P < 0.001)after LT. The strongest predictors for death in patients with BSI were hepatocellular carcinoma (HR: 3.82, 95% CI: 1.57 to 9.32,P = 0.003), candidemia (HR: 3.71, 95% CI: 1.58 to 8.71, P = 0.003), polymicrobial bacteremia (HR: 3.18, 95% CI: 1.39 to 7.28,P = 0.006), and post-transplant hemodialysis (HR: 2.44, 95% CI: 1.02 to 5.84, P = 0.044). Conclusions: BSI was a frequent post-transplant complication, and most of the causative pathogens were multi-drug resistant. Biliary complications and BSIs resulting from biliary infection are major problems for LT recipients. The prevention of BSI and biliary complications is critical in improving prognosis in liver transplant recipients.
참고문헌 (27)
- Snydman DR, "Infection in solid organ transplantation", Transpl Infect Dis, 1, pp.21~28 (1999)
- 김상일, "Epidemiology and Risk Factors for Bacteremia in 144 Consecutive Living-Donor Liver Transplant Recipients", Yonsei Medical Journal, 50(1), pp.112~121 (2009), 연세대학교의과대학
- Nah YW, "Infection after adultto-adult living donor liver transplantation", J Korean SocTransplant, 15, pp.93~105 (2001)
- Wade JJ, "Bacterial and fungal infectionsafter liver transplantation: an analysis of 284 patients", Hepatology, 21, pp.1328~1336 (1995)
- Singh N, "Predicting bacteremia and bacteremic mortality in livertransplant recipients", Liver Transpl, 6, pp.54~61 (2000)
- Iida T, "Posttransplant bacteremiain adult living donor liver transplant recipients", LiverTranspl, 16, pp.1379~1385 (2010)
- Kawecki D, "Etiological agents ofbacteremia in the early period after liver transplantation", Transplant Proc, 39, pp.2816~2821 (2007)
- Singh N, "Bacteremias in liver transplant recipients:shift toward gram-negative bacteria as predominantpathogens", Liver Transpl, 10, pp.844~849 (2004)
- Shi SH, "Multidrug resistant gram-negativebacilli as predominant bacteremic pathogens in livertransplant recipients", Transpl Infect Dis, 11, pp.405~412 (2009)
- Kim YJ, "Epidemiological data on antibiotic-resistantbacteria isolated in liver transplant recipients", J KoreanSoc Transplant, 22, pp.203~208 (2008)
- Choe EK, "Clinical significance of vancomycin resistant enterococcusin liver transplantation", J Korean Soc Transplant, 2, pp.241~247 (2006)
- Garner JS, "CDC definitions for nosocomial infections, 1988", Am J InfectControl, 16, pp.128~140 (1988)
- Magiorakos AP, "Multidrug-resistant,extensively drug-resistant and pandrug-resistantbacteria: an international expert proposal for interimstandard definitions for acquired resistance", Clin MicrobiolInfect, 18, pp.268~281 (2012)
- Hashimoto M, "Bloodstream infection after livingdonor l iver t ransplantat ion", Scand J Infect Dis, 40, pp.509~516 (2008)
- Bert F, "Microbial epidemiology and outcome ofbloodstream infections in liver transplant recipients: ananalysis of 259 episodes", Liver Transpl, 16, pp.393~401 (2010)
- Li C, "A learning curve for living donor liver transplantation", Dig Liver Dis, 44, pp.597~602 (2012)
- Kim BW, "Duct-to-duct biliary reconstructions andcomplications in 100 living donor liver transplantations", Transplant Proc, 41, pp.1749~1755 (2009)
- Hampe T, "Biliary complications after livertransplantation", Clin Transplant, 20(17), pp.93~96 (2006)
- Linares L, "Earlybacteremia after solid organ transplantation", TransplantProc, 41, pp.2262~2264 (2009)
- Albrecht SJ, "Reemergence of gram-negative health care-associatedbloodstream infections", Arch Intern Med, 166, pp.1289~1294 (2006)
- Lee SO, "Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management", Liver Transpl, 17, pp.733~741 (2011)
- Kim YJ, "Highmortality associated with Acinetobacter species infectionin liver transplant patients", Transplant Proc, 43, pp.2397~2399 (2011)
- 김윤정, "Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy", Journal of Korean Medical Science, 27(5), pp.471~475 (2012), 대한의학회
- Faenza S, "Acute renal failure requiring renalreplacement therapy after orthotopic liver transplantation", Transplant Proc, 38, pp.1141~1142 (2006)
- Nieto-Rodriguez JA, "Factors associatedwith the development of candidemia and candidemiarelateddeath among liver transplant recipients", Ann Surg, 223, pp.70~76 (1996)
- Klotz SA, "Polymicrobialbloodstream infections involving Candida species:analysis of patients and review of the literature", DiagnMicrobiol Infect Dis, 59, pp.401~406 (2007)
- Waki K, "Outcome of liver transplantationfor recipients with hepatitis B and hepatitis C virus coinfection:analysis of the UNOS data", Transplantation, 92, pp.809~814 (2011)